RESTYLANE INJECTABLE GEL
FDA premarket approval P040024/S012 · decided 2008-04-21
Approval details
- PMA number
- P040024
- Supplement
- S012
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Labeling Change - PAS
- Trade name
- RESTYLANE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2007-08-21
- Decision date
- 2008-04-21
- Days to decision
- 244 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- APPROVAL FOR REVISION OF THE RESTYLANE PRODUCT LABEL TO INCLUDE THE RESULTS OF THE POST APPROVAL STUDY.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.